Cardialysis B.V. deploys Heartlab's CardioNow

Heartlab will implement its CardioNow telecardiology and image management system for cardiovascular drug and device studies at Cardialysis B.V., a cardiology contract research organization in Rotterdam, The Netherlands.
           
With the technology, Cardialysis B.V. clients can use the web-based system to handle receipt, tracking, archiving, and analysis of complex cardiac images from hospital investigator sites around the world.
           
Heartlab's web-based CardioNow technology enables electronic sharing of patient angiograms and ultrasound studies required by cardiovascular device and drug clinical trials. Within minutes of patient enrollment, complete DICOM studies can be transferred from investigator sites to angiographic and ultrasound core worldwide labs, Heartlab said.
           
Additionally, these studies can be made available online for simultaneous review by other parties, such as clinical event committee members, safety monitoring board members and trial sponsors.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup